These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24191889)

  • 1. Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization.
    Hammar O; Roth B; Bengtsson M; Mandl T; Ohlsson B
    BMC Pregnancy Childbirth; 2013 Nov; 13():201. PubMed ID: 24191889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies.
    Ohlsson B; Veress B; Janciauskiene S; Montgomery A; Haglund M; Wallmark A
    Gastroenterology; 2007 Jan; 132(1):45-51. PubMed ID: 17241858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs.
    Cordeddu L; Bergvall M; Sand E; Roth B; Papadaki E; Li L; D'Amato M; Ohlsson B
    Scand J Gastroenterol; 2015 Mar; 50(3):291-9. PubMed ID: 25592315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis.
    Roth B; Ohlsson B
    Scand J Gastroenterol; 2013 Jan; 48(1):27-34. PubMed ID: 23148737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-Releasing Hormone and Its Physiological and Pathophysiological Roles in Relation to the Structure and Function of the Gastrointestinal Tract.
    Ohlsson B
    Eur Surg Res; 2016; 57(1-2):22-33. PubMed ID: 27089503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction.
    Ohlsson B; Ekblad E; Veress B; Montgomery A; Janciauskiene S
    BMC Gastroenterol; 2010 May; 10():48. PubMed ID: 20487533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study.
    Ek M; Roth B; Valentin L; Nordengren J; Ohlsson B
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():370-374. PubMed ID: 31213335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract.
    Sand E; Voss U; Hammar O; Alm R; Fredrikson GN; Ohlsson B; Ekblad E
    Cell Tissue Res; 2013 Mar; 351(3):521-34. PubMed ID: 23254679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
    Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
    Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal symptoms among endometriosis patients--A case-cohort study.
    Ek M; Roth B; Ekström P; Valentin L; Bengtsson M; Ohlsson B
    BMC Womens Health; 2015 Aug; 15():59. PubMed ID: 26272803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against GnRH and its receptor in patients with primary Sjögren's syndrome.
    Mandl T; Roth B; Ohlsson B
    Scand J Rheumatol; 2014; 43(4):338-48. PubMed ID: 24689972
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum.
    Ohlsson B; Sjöberg K; Alm R; Fredrikson GN
    Neurogastroenterol Motil; 2011 Nov; 23(11):1000-6, e459. PubMed ID: 21714833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).
    Bengtsson M; Hammar O; Mandl T; Ohlsson B
    BMC Gastroenterol; 2011 Nov; 11():122. PubMed ID: 22073983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome.
    Noci I; Maggi M; Fuzzi B; Biagiotti R; Ricci F; Marchionni M
    Gynecol Endocrinol; 2000 Oct; 14(5):321-6. PubMed ID: 11109971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?
    Lin Y; Kahn JA; Hillensjö T
    Hum Reprod; 1999 Apr; 14(4):885-8. PubMed ID: 10221213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.
    Feldberg D; Ashkenazi J; Dicker D; Yeshaya A; Goldman GA; Dicker D; Goldman JA
    Fertil Steril; 1989 Jan; 51(1):42-5. PubMed ID: 2521325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease.
    Lubin V; Charbonnel B; Bouchard P
    Baillieres Clin Obstet Gynaecol; 1998 Dec; 12(4):607-18. PubMed ID: 10627771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.